RenMab™ Mouse: An Innovative Platform from Biocytogen

Biocytogen provides RenMab™, RenLite™ and RenNano™ mouse platforms that are powerful tools for generating fully human antibodies in various formats.


Quality Animal Models for Improved Clinical Translation

Custom models and humanized models you can trust to ensure your research’s success.

View Our Animal Models

Evaluate Immunotherapies in vivo Using Pre-Engineered Humanized Immune Checkpoint Mice

Carefully designed and generated to maintain biological functions for reliable drug validation.

View Our Models

Highly Efficient Gene Editing Services

We offers highly effective CRISPR-Cas9-Based gene editing with fast turnaround and strict quality control.

Learn More

Preclinical Services for Drug Development

Expert In vitro and in vivo preclinical services to get you from research to clinical trials faster.

View Our Services

Innovative Models to Transform Antibody Discovery

Contact Us Today

News & Events

Antibody Engineering & Therapeutics Virtual…

Agenda  Book Now Presentation: Advancing Therapeutic Antibody discovery using RenMab/RenLite/RenMab KO immunoglobulin humanized…

Learn More
Biocytogen Enters into RenMab™/RenLite™ Licensing…

Xencor to use RenLite™ Fully Human Antibody Mouse Platform to discover novel antibody…

Learn More
Customer Stories


Our models have been published in world’s leading journals.

View all client publications

A central neural circuit for…

Abstract Although itch sensation is an important protective mechanism for animals, chronic itch remains a challenging clinical problem. Itch processing has been studied extensively at the spinal level. However, how…

Read More

Follicular CXCR5-expressing CD8+ T cells…

Abstract During chronic viral infection, virus-specific CD8+ T cells become exhausted, exhibit poor effector function and lose memory potential1,2,3,4. However, exhausted CD8+ T cells can still contain viral replication in chronic infections5,6,7,8,9,…

Read More


Global Leaders in Gene Modified Model Production

Founded in 2008, Biocytogen has become a global leader in gene-edited animal and cell model production. We have locations in Beijing, Jiangsu, Shanghai, and Boston, employing more than 800 people around the world, many of whom have advanced degrees in their fields. Over the last 10 years, we have collaborated with top pharmaceutical companies and researchers to complete more than 4,500 gene editing projects. Our fast turnaround times and dedication to superior customer service have set us apart, earning us a 98 percent customer satisfaction rating. Review our milestones here for our success and history as a global leader in gene-editing and cell model production.

Whether you reach out to us for custom gene editing services or preclinical testing, we will adapt our services to meet your needs and use our technology platforms to provide highly accurate results quickly. Fill out a form or contact us today to learn more about our services and discover how we could assist with your next project.

Meet the Experts
Back to top